Pharmzandia is a Southern California-based company focused on developing nanomedicine therapeutic solutions for the treatment of neurological degenerative conditions.
Advancements in nanotechnology provide greater flexibility in smart drug design and structural tuning based on data feedback. This approach allows for the integration of concurrent system engineering methodologies in drug development, similar to the chip design process in the semiconductor industry.
We envision a transition from "drug discovery" to "smart drug design," marking the shift from "Therapeutic 1.0" to "Therapeutic 2.0." The key to this transformation lies in the inherent capability of "design function," which enables targeted interactions between drugs and therapeutic targets.
Advancements in nanotechnology provide greater flexibility in smart drug design and structural tuning based on data feedback. This approach allows for the integration of concurrent system engineering methodologies in drug development, similar to the chip design process in the semiconductor industry.
